Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2017 Dec 1;76(4):402–408. doi: 10.1097/QAI.0000000000001510

Table 1.

Clinical and demographic characteristics at ART initiation of 597 participants in CNICS: 2011–2014.



Baseline Characteristics EFV-free ART EFV-containing ART
450 (75.4) 147 (24.6)
N(%) or Mean (SD) N(%) or Mean (SD)


Year initiated ART
 2011 79 (17.6) 76 (51.7)
 2012 121 (26.9) 39 (26.5)
 2013 138 (30.7) 25 (17.0)
 2014 112 (24.9) 7 (4.8)
Age 36 (28, 44) 34 (29, 47)
Gender
 Male 396 (88.0) 139 (94.6)
 Female 54 (12.0) 8 (5.4)
Race/ethnicity
 White, non-Hispanic 219 (48.9) 75 (51.7)
 Black, non-Hispanic 98 (21.9) 37 (25.5)
 Hispanic 95 (21.2) 26 (17.9)
 Other 36 (8.0) 7 (4.8)
HIV risk group
 MSM 304 (67.6) 114 (78.1)
 IDU 56 (12.4) 13 (8.9)
 Heterosexual 69 (15.3) 19 (13.0)
 Other 21 (4.7) 0 (0.0)
Depression and suicidal ideation
 No depression or suicidal ideation 268 (59.6) 102 (69.4)
 Depression 90 (20.0) 27 (18.4)
 Suicidal ideation, with or without depression 92 (20.4) 18 (12.2)
Antidepressant use
 Not on an antidepressant 390 (87.4) 136 (93.8)
 On an antidepressant 56 (12.6) 9 (6.2)
Panic Disorder
 No symptoms 279 (62.3) 116 (80.6)
 Some symptoms 93 (20.7) 16 (11.1)
 Panic disorder 76 (17.0) 12 (8.3)
Drug use
 No use 166 (42.7) 72 (50.7)
 Current use 113 (29.0) 29 (20.4)
 Past use 110 (28.3) 41 (28.9)
Alcohol use
 Not at risk drinking 107 (24.3) 42 (29.2)
 At risk drinking 333 (75.7) 102 (70.8)
Prior mental health diagnosis1
 No 305 (67.8) 107 (72.8)
 Yes 145 (32.2) 40 (27.2)
Prior medical diagnosis1
 No 386 (85.8) 129 (87.8)
 Yes 64 (14.2) 18 (12.2)
CD4 count, cells/mm3 390 (241, 545) 417 (276, 530)
1

At the time of ART initiation.

MSM: men who have sex with men, IDU: intravenous drug use. Missing data: race/ethnicity n=4, HIV risk group n=1, antidepressant use n=6, panic disorder n=5, drug use n=66, alcohol use n=13, CD4 count n=3.